These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1753675)

  • 21. Vogt-Koyanagi-Harada syndrome and pregnancy.
    Steahly LP
    Ann Ophthalmol; 1990 Feb; 22(2):59-62. PubMed ID: 2316953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 23. [Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
    Hiraki Y; Kuwasaki N; Shoji H; Kaji M; Kuboshiro T
    Rinsho Shinkeigaku; 1989 Jan; 29(1):54-8. PubMed ID: 2663296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK; Levy J; Rogers S; Lim LL
    Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome.
    Chan EW; Sanjay S; Chang BC
    CMAJ; 2010 Aug; 182(11):1205-9. PubMed ID: 20479047
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
    Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of Vogt-Koyanagi-Harada syndrome (author's transl)].
    Kawata K
    Fukuoka Igaku Zasshi; 1978 Nov; 69(11):473-85. PubMed ID: 738693
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY; Chan RP; Chan CK; Lam DS
    Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    de Smet MD; Rao NA
    Am J Ophthalmol; 2005 Nov; 140(5):962; author reply 962-3. PubMed ID: 16310504
    [No Abstract]   [Full Text] [Related]  

  • 31. Headache in late pregnancy: a symptom for Vogt-Koyanagi-Harada disease.
    Matsubara S; Kuwata T; Ohkawara Y; Makino S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1423-5. PubMed ID: 21046128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vogt Koyanagi Harada disease: treatment and visual prognosis.
    Alam M; Iqbal M; Khan BS; Hussain I
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
    Jap A; Luu CD; Yeo I; Chee SP
    Eye (Lond); 2008 Feb; 22(2):240-5. PubMed ID: 16980924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
    Kohnen EM; Pansdorf Y; Zubcov A
    Ophthalmologe; 2004 Apr; 101(4):390-3. PubMed ID: 15067421
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vogt-Koyanagi-Harada syndrome].
    Babushkin AE; Siuniaeva SI; Fattakhov BT; Vavilova OV
    Vestn Oftalmol; 2003; 119(2):43-5. PubMed ID: 13678012
    [No Abstract]   [Full Text] [Related]  

  • 37. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y; Gaudio PA
    Ocul Immunol Inflamm; 2008; 16(4):167-71. PubMed ID: 18716952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vogt-Koyanagi-Harada syndrome.
    Hammer H; Janáky M; Süveges I
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):711-3. PubMed ID: 8109221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
    Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.